Clinical Trials Directory

Trials / Unknown

UnknownNCT04184960

AG & IM in CA Stomach Protocol

Performance of Endoscopic and Histological Criteria of Atrophic Gastritis and Intestinal Metaplasia in Predicting Risk of Gastric Cancer - a Multicenter Case Control Study

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

This is a multi-center prospective case control study aiming to compare different methods of risk stratification models in predicting the risk of gastric cancer development.

Detailed description

The case control study would compare which type of assessment (Endoscopic / histological) is more accurate in predicting the risk of gastric cancer development. The risk factor assessment would be based on the following criteria. Endoscopic assessment: 1. Atrophic gastritis, based on Kimura Takemoto Classification 2. Kyoto classification of gastritis 3. Intestinal metaplasia, based on Endoscopic Mapping and Grading of Intestinal Metaplasia (EGGIM) Histological assessment (Based on random biopsies) 1\. Operative Links on Gastritis Assessment 2. Operative Links on Gastric Intestinal Metaplasia

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGastroscopy and gastric biopsiesGastroscopy would be performed to assess the degree of atrophic gastritis and intestinal metaplasia. In addition, four random biopsies would be taken in the stomach for histological assessment of AG and IM

Timeline

Start date
2019-12-05
Primary completion
2024-01-31
Completion
2024-03-31
First posted
2019-12-04
Last updated
2023-09-07

Locations

4 sites across 4 countries: Hong Kong, Japan, Singapore, Thailand

Source: ClinicalTrials.gov record NCT04184960. Inclusion in this directory is not an endorsement.